Drug Makers Find 'Branded Generics' Are a Source for Growth

So-called branded generics—off patent drugs backed by branding and marketing more typical of patented drugs—have given Abbott and a handful of other players a relatively cheap font of growth, especially in developing markets, allowing them to repackage off-patent drugs and extend their commercial lifespan.

from WSJ.com: US Business http://ift.tt/2zv7fX0
via IFTTT